Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
Quick Stats
Jan 30, 202637.0
AI Score
SELL0.15
Volume Ratio
Next Earnings
7
+ve Days (30d)
23
-ve Days (30d)
BDRX Stock Summary
Last updated Jan 30, 2026
BDRX is currently trading at $1.77, positioned below its 200-day moving average of $5.52, suggesting bearish momentum. The stock has a 52-week range of $0.785 to $92.
Technical Analysis: The 50-day moving average stands at $3.53, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 33.909, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.139, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates BDRX at 37.0/100 with a SELL recommendation.
BDRX (Biodexa Pharmaceuticals plc American Depositary Shs) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 33.909 |
| CMF (20) | 0.139 |
| ROC (10) | -18.433 |
| ADX (14) | 15.69 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.465 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -90.909 |
| MFI (14) | 82.284 |
BDRX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
BDRX Price vs Max Options Open Interest
BDRX Max Change In Options Open Interest
BDRX Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BDRX Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BDRX Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BDRX Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Biodexa Pharmaceuticals plc American Depositary Shs is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
BDRX Moving Averages Analysis
BDRX (Biodexa Pharmaceuticals plc American Depositary Shs) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 2.1 |
| 20 | 2.22 |
| 30 | 2.55 |
| 50 | 3.53 |
| 100 | 5.09 |
| 200 | 5.52 |
BDRX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.7 million |
| Earnings/Share ($) | -27.65 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.4 |
| EPS Estimate Next Year ($) | -0.1 |
| WallStreet Target Price ($) | 178.3005 |
| Most Recent Quarter |